Inventia Healthcare Limited, a drugmaker based in India, has recalled more than 25,000 bottles of chlorthalidone tablets, a blood pressure and fluid-retention medicine, because the pills failed dissolution specifications, according to the Food and Drug Administration. The recalls cover 25-milligram tablets that expire in April 2027 and were distributed nationwide. The FDA classified both recalls […]

The post25,000 chlorthalidone bottles recalled, here’s who it hitsappeared first onRolling Out.